Adarza News

ADARZA BIOSYSTEMS CLOSES ON $17 MILLION SERIES C FINANCING

ROCHESTER, NY and ST LOUIS, MO (Jan. 19, 2017) – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development …

ADARZA BIOSYSTEMS CLOSES ON $17 MILLION SERIES C FINANCING Read More »

Event Update

  Join us at the 15th Cytokines & Inflammation Conference, February 6-7, 2017 in San Diego, CA. Booth #6. And check our poster while you’re there: “A Multiplex Panel for Simultaneously Profiling Toxicant Levels and Biological Response Indicators in Serum Samples”.

Senior QC Manager

Adarza BioSystems, Inc. is a venture capital backed biotechnology company developing label-free protein microarray assays based on the Company’s proprietary Arrayed Imaging Reflectometry (AIR™) platform.  Adarza is seeking a Quality Manager to implement our QMS and lead the ISO 9001:2015 certification process.  Reporting to the Head of Missouri Operations, this individual will have an opportunity …

Senior QC Manager Read More »

Adarza BioSystems Completes $5 M Series-B Closing

ROCHESTER, N.Y. ST LOUIS, MO – Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed a $5 M Series B financing. Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable …

Adarza BioSystems Completes $5 M Series-B Closing Read More »

Adarza BioSystems Completes $6.8M Series-A Financing

ROCHESTER, NY:  Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed the final tranche of its Series-A financing bringing the total Series-A financing amount to $6.8 million. Proceeds from the financing will be used to launch its first 100-plex immunoassay product consumable and instrument and accelerate …

Adarza BioSystems Completes $6.8M Series-A Financing Read More »

Missouri Technology Corporation Helps to Recruit Life Science Startup to Missouri with IDEA Funds Program

NEWS RELEASE FROM: Missouri Department of Economic Development Date: Thursday, June 27, 2012 JEFFERSON CITY, MO:  The Missouri Technology Corporation (MTC) today announced a significant investment in a life science startup company through its IDEA Funds program. MTC made a $200,000 investment in Adaraza BioSystems, Inc, a life science technology company that has developed a disruptive …

Missouri Technology Corporation Helps to Recruit Life Science Startup to Missouri with IDEA Funds Program Read More »